戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 farction, or one cardiovascular death or one coronary revascularization procedure).
2 rwise uncomplicated myocardial infarction or coronary revascularization procedure.
3  thrombotic complications after percutaneous coronary revascularization procedures.
4 ages for 'fast tracking' patients undergoing coronary revascularization procedures.
5 f 60 years and at least 1 sibling with MI or coronary revascularization procedures.
6 erm survival after percutaneous and surgical coronary revascularization procedures.
7 infarction, and patients undergoing elective coronary revascularization procedures.
8 ardial infarction or stroke, or the need for coronary-revascularization procedures.
9 events; RR, 0.68; 95% CI, 0.49-0.95; P=.02), coronary revascularization procedures (157 vs 106 proced
10 , 333 (29%) first events occurred (70 AF, 67 coronary revascularization procedures, 65 CHF, 48 MI, 38
11 is of the use of cardiac catheterization and coronary revascularization procedures after AMI in milit
12 nts hospitalized from 1995 to 1998 for first coronary revascularization procedures after renal replac
13                                              Coronary revascularization procedures also appear to be
14 healthcare reform in Massachusetts on use of coronary revascularization procedures and in-hospital an
15  Recurrent MI, CHD events (recurrent MI or a coronary revascularization procedure), and mortality wer
16 myocardial infarction (MI), unrecognized MI, coronary revascularization procedures, angina pectoris,
17 tory to maximal medical therapy and standard coronary revascularization procedures are diagnosed each
18 s to apply a new method to determine whether coronary revascularization procedures are underused, esp
19  death, Q-wave myocardial infarction and any coronary revascularization procedure) at one year was si
20 fies all Medicare beneficiaries undergoing a coronary revascularization procedure: coronary artery by
21 ous studies have shown that women undergoing coronary revascularization procedures do so at a higher
22    Reducing insurance barriers to receipt of coronary revascularization procedures has not yet elimin
23 ation of CVD (myocardial infarction, angina, coronary revascularization procedure, heart failure, or
24 nts is currently the most commonly performed coronary revascularization procedure; hence, optimizing
25 0.5 mg/d was due primarily to lower risks of coronary revascularization procedures, hospitalization f
26 improve prognosis in patients who have had a coronary revascularization procedure (i.e., percutaneous
27 rdial infarction, ischemic heart disease, or coronary revascularization procedure in the cohort study
28 spective trials of surgical and percutaneous coronary revascularization procedures in dialysis patien
29                                  Underuse of coronary revascularization procedures is measurable and
30 onary artery disease, and that many elective coronary revascularization procedures may be unnecessary
31                      The decision to perform coronary revascularization procedures may hinge on asses
32 ith a diagnosis of CHD (n = 1022), including coronary revascularization procedures (n = 155).
33 nd = 0.61), and was directly associated with coronary revascularization procedures (OR = 2.38, 95% CI
34 efined as adjudicated nonfatal MI, fatal MI, coronary revascularization procedures, or death due to C
35 her than expected rates of valve surgery and coronary revascularization procedures over the next 10 t
36  P=0.009) and required a higher rate of late coronary revascularization procedures (PCI: Mod-CAD vs.
37  of cardiovascular events either following a coronary revascularization procedure (percutaneous coron
38  on the trends in the volume and outcomes of coronary revascularization procedures performed on Medic
39  These findings should influence the type of coronary revascularization procedure selected for patien
40 rs were substantially less likely to undergo coronary revascularization procedures than those without
41 dies have reported that blacks undergo fewer coronary-revascularization procedures than whites, but i
42 e use of aspirin, beta-blockers, statins, or coronary-revascularization procedures was lowest in this
43 g death, myocardial infarction [MI], and any coronary revascularization procedure) was significantly
44 ndary end point, which included undergoing a coronary revascularization procedure, was determined as
45 nts hospitalized from 1995 to 1999 for first coronary revascularization procedure were retrospectivel
46 up in the incidence of secondary outcomes of coronary revascularization procedures, worsening heart f